208 related articles for article (PubMed ID: 26588325)
1. Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation.
Lucarelli B; Merli P; Bertaina V; Locatelli F
Expert Rev Clin Immunol; 2016; 12(3):343-58. PubMed ID: 26588325
[TBL] [Abstract][Full Text] [Related]
2. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.
Perruccio K; Topini F; Tosti A; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
Blood Cells Mol Dis; 2008; 40(1):76-83. PubMed ID: 17977031
[TBL] [Abstract][Full Text] [Related]
5. T-cell therapy after hematopoietic stem cell transplantation.
Kennedy-Nasser AA; Brenner MK
Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
[TBL] [Abstract][Full Text] [Related]
6. Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation.
Tey SK; Dotti G; Rooney CM; Heslop HE; Brenner MK
Biol Blood Marrow Transplant; 2007 Aug; 13(8):913-24. PubMed ID: 17640595
[TBL] [Abstract][Full Text] [Related]
7. Advances in adoptive immunotherapy to accelerate T-cellular immune reconstitution after HLA-incompatible hematopoietic stem cell transplantation.
Reimann C; Dal Cortivo L; Hacein-Bey-Abina S; Fischer A; André-Schmutz I; Cavazzana-Calvo M
Immunotherapy; 2010 Jul; 2(4):481-96. PubMed ID: 20636003
[TBL] [Abstract][Full Text] [Related]
8. Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation.
Cieri N; Mastaglio S; Oliveira G; Casucci M; Bondanza A; Bonini C
Immunol Rev; 2014 Jan; 257(1):165-80. PubMed ID: 24329796
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution following hematopoietic stem-cell transplantation.
Novitzky N; Davison GM
Cytotherapy; 2001; 3(3):211-20. PubMed ID: 12171728
[TBL] [Abstract][Full Text] [Related]
10. Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children.
Eyrich M; Wollny G; Tzaribaschev N; Dietz K; Brügger D; Bader P; Lang P; Schilbach K; Winkler B; Niethammer D; Schlegel PG
Biol Blood Marrow Transplant; 2005 Mar; 11(3):194-205. PubMed ID: 15744238
[TBL] [Abstract][Full Text] [Related]
11. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation.
Amrolia PJ; Muccioli-Casadei G; Huls H; Adams S; Durett A; Gee A; Yvon E; Weiss H; Cobbold M; Gaspar HB; Rooney C; Kuehnle I; Ghetie V; Schindler J; Krance R; Heslop HE; Veys P; Vitetta E; Brenner MK
Blood; 2006 Sep; 108(6):1797-808. PubMed ID: 16741253
[TBL] [Abstract][Full Text] [Related]
12. Adoptive immunotherapy with virus-specific T cells.
Fuji S; Kapp M; Grigoleit GU; Einsele H
Best Pract Res Clin Haematol; 2011 Sep; 24(3):413-9. PubMed ID: 21925094
[TBL] [Abstract][Full Text] [Related]
13. Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.
Toubert A; Glauzy S; Douay C; Clave E
Tissue Antigens; 2012 Feb; 79(2):83-9. PubMed ID: 22220718
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid reconstruction and vaccines.
Gress RE; Komanduri KV; Einsele H; Cooper LJ
Biol Blood Marrow Transplant; 2007 Jan; 13(1 Suppl 1):17-22. PubMed ID: 17222765
[TBL] [Abstract][Full Text] [Related]
15. Adoptive antifungal T cell immunotherapy--into the clinic?
Lehrnbecher T; Schmidt S; Koehl U; Schuster FR; Uharek L; Klingebiel T; Tramsen L
Med Mycol; 2011 Apr; 49 Suppl 1():S164-9. PubMed ID: 20586680
[TBL] [Abstract][Full Text] [Related]
16. Adoptive Immunotherapies After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies.
Xiong Y; Bensoussan D; Decot V
Transfus Med Rev; 2015 Oct; 29(4):259-67. PubMed ID: 26282736
[TBL] [Abstract][Full Text] [Related]
17. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
[TBL] [Abstract][Full Text] [Related]
18. The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment.
Velardi E; Clave E; Arruda LCM; Benini F; Locatelli F; Toubert A
Semin Immunopathol; 2021 Feb; 43(1):101-117. PubMed ID: 33416938
[TBL] [Abstract][Full Text] [Related]
19. Control of leukemia relapse after allogeneic hematopoietic stem cell transplantation: integrating transplantation with genetically modified T cell therapies.
Dotti G
Curr Opin Hematol; 2015 Nov; 22(6):489-96. PubMed ID: 26335421
[TBL] [Abstract][Full Text] [Related]
20. Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγc null mice.
Thomas S; Klobuch S; Sommer M; van Ewijk R; Theobald M; Meyer RG; Herr W
Exp Hematol; 2014 Jan; 42(1):28-38.e1-2. PubMed ID: 24120693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
